Management of cutaneous dermatomyositis. - Wikidata - awgldk - TriplyDB

Management of cutaneous dermatomyositis.

Management of cutaneous dermatomyositis.

http://www.wikidata.org/entity/Q38022271

about

Unilateral heliotrope rash in juvenile dermatomyositis: an unusual presentation of an underlying serious disease.The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy.Sustained autoimmune mechanisms in dermatomyositis.

P2860

Q43089975-D88F33F8-86AA-4D8C-A5B7-59BEB0B13BBD Q47103957-830BF9FF-0E7E-4D9F-BA33-DE75D6230071 Q53059776-0A33B96B-7445-4129-8FA0-DEBD69CB1CBF

P2860

Management of cutaneous dermatomyositis.

http://www.wikidata.org/entity/Q38022271

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of cutaneous dermatomyositis.

@en

type

label

Management of cutaneous dermatomyositis.

@en

prefLabel

Management of cutaneous dermatomyositis.

@en

P1433

Q38022271-AAC35C79-A223-48A3-BE40-52E063509DE4

P1476

Q38022271-AD9D005C-E1CE-4DE2-826D-E85F473C51DB

P2093

Q38022271-6B4A7643-B6A5-42FE-92E1-1814028D28A4

P2860

Q38022271-000FDA76-906B-433A-B055-E35079D16E74

Q38022271-01E566C8-E2F2-4FAB-8491-7605F9A742E4

Q38022271-02C3E4CC-5C17-417B-A87A-F46A5683F4D6

Q38022271-02D8651F-5056-4438-8C3A-A35E3BC91DFA

Q38022271-06AB85A1-D8D5-4601-AA8A-18F21D492789

Q38022271-06C9F55F-5F92-4C81-A87F-EDAC255B7CE5

Q38022271-076E265B-3C8F-4CCD-94B2-CA347253A1FF

Q38022271-0795F3CA-2210-430C-9705-2EC2D571B29D

Q38022271-09222C14-1B37-438B-ADA2-577B5C313576

Q38022271-0B188E27-90A5-4081-A1E6-9573FB2A3E2F

P304

Q38022271-AD2D7BE8-6012-4987-973A-37BE2B24BC18

P31

Q38022271-1C6BA8CE-20EC-4A8A-A2E3-701252AB5068

P356

Q38022271-C4956823-93A1-42C7-B6A4-C84B6F340D00

P433

Q38022271-EE4B3B31-6F99-48F6-8B6B-16E506B80BE4

P478

Q38022271-83A2B9A6-9F07-41F0-B036-DAC49FEA47DE

P50

Q38022271-581EBD0A-C889-486D-A569-36FEAE11548B

P577

Q38022271-D077B798-2A36-4170-B2FA-C340913C0F66

P698

Q38022271-379513A3-F2DB-4A5C-B1A4-CC182ADAE8D9

P921

Q38022271-D7A28DD1-8AA2-4E5C-8610-FB9FF7B3AD47

P356

J.1529-8019.2012.01491.X

P1433

Dermatologic Therapy

P1476

Management of cutaneous dermatomyositis

@en

P2093

Ruth Ann Vleugels

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases

Cyclosporin in the management of polymyositis and dermatomyositis

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis

Myositis overlap syndromes.

Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.

Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.

P304

112-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1529-8019.2012.01491.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22741932

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis